Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo
Research output: Contribution to journal › Journal article › Research › peer-review
Neuroglobin is considered to be a novel important pharmacological target in combating stroke and neurodegenerative disorders, although the mechanism by which this protection is accomplished remains an enigma. We hypothesized that if neuroglobin is directly involved in neuroprotection, then permanent cerebral ischemia would lead to larger infarct volumes in neuroglobin-null mice than in wild-type mice.
Original language | English |
---|---|
Journal | Experimental & Translational Stroke Medicine |
Volume | 4 |
Issue number | 1 |
Pages (from-to) | 15 |
ISSN | 2040-7378 |
DOIs | |
Publication status | Published - 2012 |
ID: 47927681